The promise and reality of fixed-dose combinations with rifampicin

Publisher Website

1 June 1994

journal article
guideline
Published by Elsevier in Tubercle and Lung Disease

Vol. 75 (3) , 180-181
https://doi.org/10.1016/0962-8479(94)90004-3

Abstract

No abstract available

This publication has 2 references indexed in Scilit:

Drug combinations and the bioavailability of rifampicin
Tubercle, 1990
United states public health service tuberculosis therapy trial 21: Preliminary results of an evaluation of a combination tablet of isoniazid, rifampin and pyrazinamide
Tubercle, 1987